Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002460263 | SCV002618052 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-12-11 | criteria provided, single submitter | clinical testing | The p.D1192Y variant (also known as c.3574G>T), located in coding exon 19 of the BRIP1 gene, results from a G to T substitution at nucleotide position 3574. The aspartic acid at codon 1192 is replaced by tyrosine, an amino acid with highly dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |